Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report - Wikidata - awgldk - TriplyDB

Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report

Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report

http://www.wikidata.org/entity/Q34064492

about

Medical treatment update on pulmonary arterial hypertension Pulmonary hypertension: diagnostic and therapeutic challenges The molecular targets of approved treatments for pulmonary arterial hypertension Clinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentan A Review of Targeted Pulmonary Arterial Hypertension-Specific Pharmacotherapy Treatment-related biomarkers in pulmonary hypertension Potential new drug treatments for congestive heart failure.Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.Targeted drugs for pulmonary arterial hypertension: a network meta-analysis of 32 randomized clinical trials.Phosphodiesterase type 5 inhibitor to riociguat transition is associated with hemodynamic and symptomatic improvement in pulmonary hypertension Role of prostacyclin in pulmonary hypertension.Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers Case report: a patient with pulmonary arterial hypertension transitioning from a PDE-5 inhibitor to Riociguat.Comparative Effectiveness of Pharmacologic Interventions for Pulmonary Arterial Hypertension: A Systematic Review and Network Meta-Analysis.Pulmonary Hypertension: Scientometric Analysis and Density-Equalizing Mapping.Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based review.Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia.Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center.Plasma 12- and 15-hydroxyeicosanoids are predictors of survival in pulmonary arterial hypertension.Prevalence of Sodium and Fluid Restriction Recommendations for Patients with Pulmonary Hypertension Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study.How to select the appropriate candidate of pulmonary arterial hypertension: specific therapy in elderly patients with pulmonary hypertension.New pharmacotherapies for pulmonary hypertension: where do they fit in?Pharmacokinetic and pharmacodynamic evaluation of macitentan , a novel endothelin receptor antagonist for the treatment of pulmonary arterial hypertension.Perioperative management of patients with pulmonary hypertension for non-cardiac surgery.What's new in the treatment of portopulmonary hypertension?Riociguat: a novel new drug for treatment of pulmonary hypertension.Development of macitentan for the treatment of pulmonary arterial hypertension.Origin and production of inflammatory perivascular macrophages in pulmonary hypertension.An Update on the Management of Pulmonary Arterial Hypertension and the Pharmacist's Role.Selexipag, an Oral Prostacyclin-Receptor Agonist for Pulmonary Arterial Hypertension.Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency.Current and future direction in the management of scleroderma.The prostacyclin pathway in pulmonary arterial hypertension: a clinical review.Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.A review of therapeutic agents for the management of pulmonary arterial hypertension.New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment.Selexipag: A Review in Pulmonary Arterial Hypertension.Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health.Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension.

P2860

Q26785995-BBB34FBE-0827-4712-8D30-B8ED44D6D0A8 Q26796434-1CD82E68-AED4-4E1F-9E6E-59D023946887 Q26798308-03733703-C642-4FAA-AAB4-BADEC64FC74E Q26851546-8311A3A0-AE6D-454F-85C4-68BFE191D4E0 Q28072562-10D3422A-811C-4100-96D2-7D4559C66C98 Q28081276-90765827-ACCA-49C8-9B62-6E1BAE1872C2 Q30251531-E1ACAAFB-367E-4A13-8B80-EB5A2AB781D1 Q33596457-7343D19F-5A30-46B3-80D4-15725BEB199D Q33673947-C6A1B2C5-5177-46A2-B60D-3C789CCE674B Q33788560-D94E636E-B5D6-4D85-A4DC-368BE3812740 Q35165100-4C8EC0B2-BC29-4882-A059-1C0015A8C551 Q35665777-2054993C-5B70-470B-AEE5-E823DB52E4DF Q36021594-76F9A53F-DFA1-4CE3-B7F6-99BB7B2262E4 Q36129391-C9F9C0BF-3628-4ABF-AB05-0C1DECF696FB Q36239561-0E10E38A-8C83-4C47-A529-CA4C0591FDA1 Q36257077-E33D6BA7-6E2F-4F8E-A8F8-818FE25ADAAA Q36343915-17376B99-243C-4A9B-8CA1-B8B251BE441F Q36363156-8CE60F10-CB45-4F80-A448-C0545AAC88C6 Q36908857-E5237741-8FD9-4381-AF53-D42E4953F496 Q37081642-87312775-1C5E-4662-A83C-A44B43339CE3 Q37094621-1D9B53FB-531D-4718-9C86-9CAEE54B6DB1 Q37670924-BB5647DD-A530-4810-8BFF-750CE753E09C Q38258961-AD691E15-1B65-42FC-A060-823A77F8CDFF Q38325919-31B00B9A-48BF-4C83-822F-B0509FC45568 Q38367774-9CBCE00F-CB8E-49CB-969D-768E5DDAC029 Q38424573-493159B0-9469-4BAF-BA86-B1EE3A56059B Q38502798-84BBDFE0-4E8C-4F8B-89AC-7B2289F750DF Q38570060-52EC027B-5945-4089-B9F1-24B8D9E1DE1C Q38601788-02A94022-9F9B-4671-8B8C-0B62E987BC5D Q38651227-83EF7F70-5BD4-4F0D-A0C0-32206C804BDD Q38800077-65888662-A619-470A-8372-8585F1DD8219 Q38806549-1354E483-F4B1-4119-9422-1746DFEFE028 Q38823948-C748146C-6589-40C2-9132-EED9632A3883 Q38841958-D37B5EEE-6576-4B56-9D1D-78670F294375 Q38904855-82FF39A4-5697-491B-BC93-82AE2CDF1057 Q38946618-068C9714-7408-469F-950D-AC73811580D5 Q38955252-F711CD16-5E3E-40FE-87AF-BC47E9D4C5B8 Q39042343-ADDA4F1B-7002-46DB-8A1D-F3398555A500 Q39042753-7C8326AB-31CD-4716-AFFA-657465638BDA Q40243009-860B54FD-F297-47B4-B109-3E2E51ADD9F6

P2860

Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report

http://www.wikidata.org/entity/Q34064492

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Pharmacologic therapy for pulm ...... deline and expert panel report

@ast

Pharmacologic therapy for pulm ...... deline and expert panel report

@en

Pharmacologic therapy for pulm ...... deline and expert panel report

@nl

type

label

Pharmacologic therapy for pulm ...... deline and expert panel report

@ast

Pharmacologic therapy for pulm ...... deline and expert panel report

@en

Pharmacologic therapy for pulm ...... deline and expert panel report

@nl

prefLabel

Pharmacologic therapy for pulm ...... deline and expert panel report

@ast

Pharmacologic therapy for pulm ...... deline and expert panel report

@en

Pharmacologic therapy for pulm ...... deline and expert panel report

@nl

P1433

Q34064492-4338AFDB-E6FF-4D7B-A0A8-A0EAC6A6E909

P1476

Q34064492-0A7AABA6-6B56-4621-813C-3B4A7D556D23

P2093

Q34064492-32FF839F-64E4-4936-A460-3AE06642A87C

Q34064492-354629AB-63D4-4789-BF61-E3D0C7D72475

Q34064492-46EF5404-DD60-4355-9D26-87B2CBD9E826

Q34064492-4D79C309-9692-4AC8-9902-6888A0C12EE2

Q34064492-5466C992-C2A1-4AA4-AC7B-3CC8B39A8AC6

Q34064492-66348C42-4FDB-4F86-9726-0CCF79779E38

Q34064492-9A5AD8B7-4EAA-45AB-86D4-317E4592A198

Q34064492-9B39A1BF-1E91-4E92-B7FE-18B97D738647

Q34064492-AC017A56-BBBE-4C15-8FB3-111EFFFF7F05

Q34064492-AD5E5CEC-939E-4331-BEC9-255F0A1FF15F

P2860

Q34064492-02E1AB4E-6604-4223-8703-F00EF069904A

Q34064492-07F8011A-57E6-45DF-A6A0-BE58F58C0055

Q34064492-0A3E43D7-4E5E-4BE9-A1AA-3F1288C6AE9E

Q34064492-0D6600E5-E95E-4F30-9DC5-9DF67ED17351

Q34064492-0DC8859B-7380-408F-AD9F-EE678E1D859F

Q34064492-12DB4830-10E4-45A0-9662-8C62747EED3C

Q34064492-1568D6EC-008F-4CED-A7AD-D0C827526F1B

Q34064492-16148E8E-3797-4988-9422-F0EEDBD3BDB8

Q34064492-17FC8CA5-C1FD-491F-9F85-C05CF9FE6A01

Q34064492-181C9A47-C126-4A38-B95F-43D279B24A4C

P304

Q34064492-5D2397D2-8BDC-4E8F-A0B1-DC29AB162123

P31

Q34064492-CC3865B1-4C10-4A69-B011-89083509AF89

P356

Q34064492-5B5AEDAB-BEE9-4E57-A3D0-3C2BB2C1EFC3

P407

Q34064492-D736E38C-F968-4176-8756-7E4C951BF34A

P433

Q34064492-FD550B6C-0398-4958-B8B0-1D15DC2C1F0B

P478

Q34064492-67F22BA5-1BBB-4538-88B9-81B75BDAE20D

P50

Q34064492-D64D311D-13D2-4657-9BC9-F4530B449247

P577

Q34064492-FAF86E12-8503-4F7A-9CD2-AF55CBB860C3

P698

Q34064492-B32CD563-EC4E-4027-9D68-D2EBB6AA07B7

P921

Q34064492-B48E5DED-379A-4E0F-AE84-6249DC13E9EA

P932

Q34064492-A522C70E-A0A6-4D04-B478-AE05547D5971

P356

P1433

P1476

Pharmacologic therapy for pulm ...... deline and expert panel report

@en

P2093

C Gregory Elliott

http://www.w3.org/2001/XMLSchema#string

David B Badesch

http://www.w3.org/2001/XMLSchema#string

Erika B Rosenzweig

http://www.w3.org/2001/XMLSchema#string

Harold I Palevsky

http://www.w3.org/2001/XMLSchema#string

James R Klinger

http://www.w3.org/2001/XMLSchema#string

Jess Mandel

http://www.w3.org/2001/XMLSchema#string

Joe Ornelas

http://www.w3.org/2001/XMLSchema#string

Lorinda Chung

http://www.w3.org/2001/XMLSchema#string

Namita Sood

http://www.w3.org/2001/XMLSchema#string

Rex Yung

http://www.w3.org/2001/XMLSchema#string

P2860

Grading quality of evidence and strength of recommendations

Treatment goals of pulmonary hypertension

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin)

Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

Bloodstream infections in patients given treatment with intravenous prostanoids.

Cesarean section under epidural ropivacaine 0.75% in a parturient with severe pulmonary hypertension.

Pregnancy and primary pulmonary hypertension : successful outcome with epoprostenol therapy.

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

P304

449-475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.14-0793

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

146

http://www.w3.org/2001/XMLSchema#string

P50

Darren B Taichman

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24937180

http://www.w3.org/2001/XMLSchema#string

P921

P932

4137591

http://www.w3.org/2001/XMLSchema#string